Question

Which countries run stem-cell trials for Liver Cirrhosis?

19 countries host at least one registered site; China alone accounts for around 54% of mentions in this snapshot (2026-08-29).

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

Country distribution

CountryStudies with a site there
China38
Iran6
Vietnam4
South Korea4
Turkey (Türkiye)4
Japan3
Indonesia3
Singapore3
India3
Italy2

A study with sites in several countries is counted once per country, taken from the location block of each registry record.

What the map means for Liver Cirrhosis

Registered work clusters where hepatology and transplant services coexist, particularly in Asia and parts of Europe. Because transplant is the established option, the honest question for any overseas offer is how it affects transplant candidacy and follow-up at home.

Where recruitment is actually open

CountryOpen studies with a site there
China3
South Korea1
Turkey (Türkiye)1
France1

What travelling for a trial actually involves

Cross-border participation fails on logistics more often than on eligibility: follow-up schedules, local insurance, visa duration and who pays for complications. A site that cannot answer those in writing is not going to enrol you.

Multi-country studies, named

Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.

  • NCT06823713 — RTX001 Autologous Engineered Macrophages for Liver Cirrhosis (Spain, United Kingdom)

Why trial geography is not a shortlist

Where studies happen reflects who funds and who authorises them. Treating that as a ranking of care quality confuses the research system with the treatment market, two things that overlap far less than medical-tourism marketing implies.

Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.

When these studies started

Registrations by start year since 2020: 2020 (1), 2021 (6), 2022 (2), 2023 (4), 2024 (5), 2025 (4), 2026 (1). Activity for this condition spans 2005 to 2026, which shows whether interest is growing, flat or past its peak.

Frequently asked

Which countries run stem-cell trials for Liver Cirrhosis?

Sites are registered in 19 countries; the largest is China (~54% of country mentions, 2026-08-29).

Does a country with many trials mean better treatment there?

It does not follow. A country can host many trials and still have an unregulated commercial sector selling something quite different to visitors.

Are trial sites and commercial clinics the same thing?

Mostly no. Some clinics imply an association with local research institutions; the registry record names the actual sponsor and site, which settles it.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads